Physician profile
Stuart Anthony Abel
NPI 1750761516
$7,681.26
in general payments reported to CMS, 2019-2025
8 companies · $24.71 in 2025
The $24.71 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2022: $1,078 · 2023: $5,841 · 2024: $357 · 2025: $24.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,800 · Travel and Lodging: $1,504 · Education: $1,000 · Food and Beverage: $902 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,800.00 |
| Travel and Lodging | $1,504.27 |
| Education | $1,000.00 |
| Food and Beverage | $902.18 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,719.65 | 2022-2024 | Da Vinci Surgical System, Davinci Xi |
| Flexdex INC. | $2,800.00 | 2023 | |
| Medtronic, INC. | $506.59 | 2022-2025 | Signia, Maxtack, Ligasure |
| Covidien LP | $225.78 | 2019 | |
| Davol INC. | $154.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $130.54 | 2024 | |
| Medical Device Business Services, INC. | $102.75 | 2023 | |
| Boston Scientific Corporation | $41.43 | 2023-2024 | Bodyguardian |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Abel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.